EXASNEUTRAL

EV/EBITDA

169.2x

Higher than 100% of Healthcare sector peers

Updated 1078h ago

Sector Performance

100th percentile

EXAS

169.2x

Sector Median

12.8x

Sector Avg

15.6x

📊

Deep Analysis

Exact Sciences Corporation (EXAS) has a EV/EBITDA of 169.2x as of May 2026.

This places EXAS in the 100th percentile of the Healthcare sector, which has a median EV/EBITDA of 12.8x and a sector average of 15.6x. EXAS's EV/EBITDA is 1222.5% above the sector median, a significant divergence that warrants closer examination. In context: A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

Frequently Asked Questions

What does the EV/EBITDA tell investors about EXAS?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does EXAS's EV/EBITDA compare to its sector?

EXAS's EV/EBITDA of 169.2x compares to a Healthcare sector median of 12.8x, placing it in the 100th percentile.

Who are EXAS's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: GSK (10.2x), CPRX (10.1x), ZBH (9.7x), BAX (9.4x), BIIB (8.8x).

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.